Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
primary hyperaldosteronism | CLCN2* | Clcn2* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | CRH | Crh* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | NR3C1 | Nr3c1* | 1 model | Alliance of Genome Resources | |||
ACTH-independent macronodular adrenal hyperplasia 1 | GNAS* | Gnas | Alliance of Genome Resources | ||||
ACTH-independent macronodular adrenal hyperplasia 2 | ARMC5* | Armc5 | Alliance of Genome Resources | ||||
glucocorticoid-remediable aldosteronism | CYP11B1*, CYP11B2 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
primary hyperaldosteronism | KCNJ5* | Kcnj5 | Alliance of Genome Resources | ||||
primary hyperaldosteronism | CACNA1H* | Cacna1h | Alliance of Genome Resources | ||||
primary hyperaldosteronism | CYP11B1*, CYP11B2* | Cyp11b1, Cyp11b2 | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
primary hyperaldosteronism | Tg(Crh)227.1Pbl | 1 model |